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Editors’ Note: In WriteClick this week, Dr. Bej traces the
changing names and dominions of the city currently called
L’viv, Ukraine, birthplace of Irena Hausmanowa-Petrusewicz,
MD, PhD. In reference to “Cause of death and predictors of
mortality in a community-based cohort of people with epilepsy,”
Drs. Nevalainen and Ansakorpi and authors Sander et al.
discuss the relationship between cause of death and
epilepsy etiology as well as the concerning increased risk of
death from neoplasms in patients with epilepsy.
—Megan Alcauskas, MD, and Robert C. Griggs, MD
IRENA HAUSMANOWA-PETRUSEWICZ, MD, PHD
(1917–2015)
Mark D. Bej, Oberlin, OH: Dr. Hausmanowa-
Petrusewicz’s In Memoriam mentioned she studied
in “Lvov.”1
A consequence of Europe’s frequent changes to
national borders (usually via conquest) is that most
large cities have multiple names or spellings, depend-
ing on the language in use (or imposed). Thus, we
have Geneva/Génève/Genf, Vienna/Vienne/Wien,
Bratislava/Preßburg/Pozsony, Breslau/Wrozław, and
so forth. “Lvov” (Львов) is the Russian version of
the name of the city in question, which has never
been ethnically Russian.
In the year 1917, in Lemberg (as the city was known
then and now to German speakers), Dr. Haumanowa-
Petrusewicz would have been born an Austrian citizen.
With Poland’s reconstitution in 1918, the city would
then be known as Lwów (roughly pronounced, “Lvoof”).
During Soviet control (1939–1941, 1945–1991) “Lvov”
was used. The West tended to follow along, using Rus-
sian names for all cities in the USSR, local majority
ethnicities notwithstanding. Given Ukraine’s indepen-
dence since 1991, “L’viv” (Львів, pronounced “Lveew,”
with a soft “L”) should be used presently.
As such, the use of “Lvov, Poland” in the obituary
is anachronistic (and anatopistic). The best construc-
tion would be either “Lwów, Poland (now L’viv,
Ukraine)” or “L’viv, Ukraine (then Lwów, Poland).”
Author Response: Anna Kaminska, Warsaw,
Poland; Paul E. Barkhaus, Milwaukee: In the In
Memoriam for Professor Hausmanowa-Petrusewicz,1
we used the Russian (Lvov) spelling (using the interna-
tional phonetic alphabet [IPA]) of the city where her
parents had originated. Dr. Bej has carefully reviewed
the orthographic transmutations of what is currently
L’viv, Ukraine. This city’s name has undergone several
changes in spellings in the past century, commensurate
with its changes in sovereignty. However, the variations
in the city’s name are particularly difficult for those unfa-
miliar with Cyrillic script and who rely on the IPA for
spelling and pronunciation. We agree with Dr. Bej’s
proposed phrasing of how to refer to this historic center,
presumably basing the phrasing on current political sov-
ereignty. Our choice for the spelling (“Lvov”), rather
than the Polish spelling “Lwów” was intended to be
phonetic as the “w” in Polish is pronounced as a “v.”
Dr. Bej’s admonition that our usage is “anatopistic”
appears somewhat extreme. We infer that he wishes to
ensure that the spelling of L’viv is pari passu with its
current sovereignty. However, we expostulate that
referring to a term or proper noun in another language
would be necessarily subject to linguistic opprobrium.
Presumably, to a Russian, Lvov (IPA) would still be
correct without implying that it is not a Ukrainian city.
We have not had any Polish colleagues, or Dr. Bej,
object to our use of Warsaw in our article rather than
the Polish spelling, Warszawa. Let us rather remember
the focus of the article, Professor Hausmanowa-
Petrusewicz, who was a key figure during some of
the turbulent historical times to which Dr. Bej refers,
and her successful efforts in international cooperation
and collaboration in neurology.
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CAUSE OF DEATH AND PREDICTORS OF
MORTALITY IN A COMMUNITY-BASED COHORT
OF PEOPLE WITH EPILEPSY
Olli Nevalainen, Tampere, Finland; Hanna
Ansakorpi, Oulu, Finland: Keezer et al.1 mentioned
that in addition to the current study, “only one other
study has investigated the relationship between epi-
lepsy etiology and causes of death (COD).” They
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cited a cohort study of patients with any kind of first
afebrile epileptic seizure, which by definition has a dif-
ferent case mix than a cohort of epilepsy patients.2
At least 4 studies have previously published estimates
on the relationship between epilepsy etiology and
COD.3 Indeed, cardiovascular disease and cancer
are a major COD in epilepsy, and the excess of deaths
from cerebrovascular disease and ischemic heart dis-
ease have been associated with symptomatic etiologies
of epilepsy.3 Keezer et al. also discussed the high death
rate from neoplasms in epilepsy.1 It is important to
note that excess deaths from neoplasms are not only
related to symptomatic etiologies. We estimated
a 56% excess in cancer mortality even in individuals
with idiopathic/cryptogenic epilepsy.3 Apart from
potential biases and residual confounding, the impact
of lifestyle-related factors and antiepileptic medica-
tion should be investigated further. The epidemiology
of epilepsy-related mortality was recently reviewed in
detail, which is useful for future studies to identify
gaps in our current knowledge on the issue.3,4
Author Response: Josemir W. Sander, Gail S. Bell,
Mark R. Keezer, London: We thank Drs. Nevalai-
nen and Ansakorpi for the comment on our article,1
and for continuing to make important contributions
to our evolving understanding of premature mortality
in epilepsy.
It appears our statement regarding COD and epi-
lepsy etiology was unclear as it seems misinterpreted.
We specifically referred to studies that investigated
how often these 2 entities are one and the same. None
of the studies referenced by Nevalainen et al.3 explic-
itly examined this particular phenomenon. We agree
that the one study we cited reports a heterogeneous
sample population.2 The data we presented, however,
were limited to those with a first unprovoked and
symptomatic seizure. Nevertheless, we agree that
the participants had only a single epileptic seizure.
Our article, therefore, appears to be one of the first
to investigate the relationship between epilepsy
(rather than a first unprovoked seizure) etiology and
COD.
We also agree the increased risk of death from neo-
plastic disease, among those in which this is not the
cause of their epilepsy, demands further investigation.
Additionally, we report that among the 41 individuals
who died of noncerebral neoplasms, only 29% had
metastatic cerebral disease.
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